Can You Get CBD Gummies In Australia

CBDISTILLERY

Buy CBD Oil Online

CBD gummies are delicious and packed full of CBD. Find out more on the health and medicinal benefits of CBD gummies and how to access them in Australia. The sale of low-dose cannabidiol preparations over the counter at Australian pharmacies has been allowed since early this year. But you won't find any at your local chemist and there is a reason for that

CBD Gummies – What, Why and Where to buy in Australia

CBD products are quickly gaining popularity among Australian medical patients. CBD is known to have an assortment of therapeutic benefits and relieve an array of medical conditions. Although most popular in oil form, edibles like gummies provide an alternative method of consuming CBD.

In this article, we will outline some background on CBD gummies, how they are made and how you can access them in Australia.

What is CBD

CBD (aka Cannabidiol) is one of the many chemical compounds called cannabinoids found in cannabis. Unlike THC (Tetrahydrocannabinol), which is the main psychoactive component of cannabis, CBD does not make you high.

We have no doubt you have already heard of the many health benefits of CBD. From relieving symptoms like pain, inflammation, seizures &amp epilepsy, to helping with PTSD, depression, anxiety and more.

CBD oils are currently the most common CBD product in the Australian market. The oil is created by isolating and extracting the CBD from a high CBD strain, and then further processed by diluting it with a carrier oil like coconut or hemp seed oil.

Please check out our complete guide to CBD oil in Australia for a more in-depth article on CBD oils.

CBD gummies

CBD gummies are precisely what they sound like – a CBD edible in a gummy candy form.

CBD gummies are generally more accessible and discrete delivery method compared to other forms of CBD. Smoking cannabis flower or using dry herb vaporizers are still somewhat controversial and sometimes known to have negative health impacts. Some patients may also dislike the taste of CBD oil or are unable to swallow capsules.

This is where CBD gummies shine – they are discrete enough to consume in public and are easily chewed and swallowed, just like a regular gummy.

How CBD gummies work

Once the CBD gummy is consumed, it is absorbed by our gastrointestinal system and works its way to our liver and through to our circulatory system. The CBD is then released and interacts with tiny receptors within our endocannabinoid system (ECS) – altering our mood and bodily functions.

As our digestive system works at a relatively slow pace, it usually takes around 30 – 60 minutes for the effects to kick in. However, edibles are also one of the longer lasting delivery methods, with effects generally lasting longer than when inhaling or taken sublingually (tinctures).

Will CBD gummies make you high?

CBD by itself is non-psychoactive and will not give you the high or intoxicating effects associated with marijuana. The main psychoactive compound found in cannabis is THC, which is another cannabinoid found in marijuana plants.

There are three types of CBD products on the market:

CBD isolate – contains only CBD without any other cannabinoids

Broad-spectrum CBD – contains CBD and other cannabinoids, but generally no THC

Full-spectrum CBD – contains all cannabinoids from the cannabis plant, including THC.

In general, CBD isolate and broad-spectrum gummies contains little to no THC, and will not make you high. Refer to the manufacturers labelling to determine whether the product is free of THC.

Health benefits of CBD gummies

CBD has recently gained mainstream popularity due to its alleged therapeutic properties and medical applications. Recent research has demonstrated huge potential into supporting a variety of conditions including:

As a side note, there may be some potential side-effects with using CBD products. We strongly encourage our readers to consult a GP or a specialist clinic prior to administering any CBD products.

How CBD gummies are made

CBD gummies are generally made using the classic gummies recipe – sugar, glucose syrup, flavouring, citric acid, gelatin and food colouring. The secret ingredient, of course, is the added CBD extract.

See also  CBD Oil San Antonio

Extracting CBD from cannabis is a complex process, usually involving using some form of solvent to separate the active compounds from the raw plant. Below are a few different methods of CBD extraction:

Once the CBD is extracted, further processing is done to combine the CBD isolate and gummy formula into the final product.

As with other confectionery products, the ingredients used in CBD gummies may vary. Some offerings may contain additives such as preservatives and artificial ingredients.

Patients with allergies and vegan requirements may be able to find products more suited to their needs. Look for organic products made with real sugar and natural flavourings.

Are CBD gummies legal in Australia?

As of Feb 2021, the Therapeutic Goods Administration (TGA) has allowed the sale of low dose CBD products over the counter. Unfortunately, companies wanting to supply low dose CBD products will require their product to be listed on the Australian Register of Therapeutic Goods (ARTG). This process involves rigorous testing and clinical trials before they can be officially sold by pharmacies. Due to the long approval process and many other factors, we are still yet to see any CBD products available over the counter as of today.

For Australians wanting to CBD gummies, there is currently only one legal pathway.

Similar to other cannabis products, access to CBD products requires TGA (Therapeutic Goods Administration) approval.

The process usually involves a consultation with a medical practitioner to determine your eligibility based on your medical history and condition. If CBD product is deemed suitable by the doctor, they will apply for approval on your behalf through the TGA.

Once approved, the doctor will provide you with a valid prescription and outline the process to obtain the CBD product depending on your state.

Legalities aside however, many Australians have resorted to buying CBD gummies on the grey market since the medical pathway is not the most straight forward.

How to choose CBD gummy products

Since CBD gummies come in different shapes and forms, it is hard to tell whether you are purchasing the right product. Below are a few points to consider when selecting the right CBD gummy brand.

Organically grown Cannabis

As CBD is extracted from cannabis, the source of the raw plant can have a huge effect on the end product. In our opinion, organically source will contain less toxins, pesticides, and other residuals that may affect the quality of the end product, and will be better for the environment.

Organic Ingredients

As mentioned earlier, organic ingredients would be ideal for patients which may be sensitive to artificial flavouring and colours.

There may also be soy-free, non-GMO, gluten-free and vegan options to suit different dietary requirements.

Most CBD gummy products will specify the amount of CBD per serving (E.g. 10mg CBD per gummy).

To get the best bang for your buck, work out the total serving size and CBD per mg vs the product price – but keeping into consideration the product quality as mentioned above.

Most reputable companies will have their product cannabinoid content lab tested by a third party. This ensures you are actually getting the CBD content that is advertised on the product.

It is best to avoid products which do not stipulate individual cannabinoid content or simply specifies “cannabis extracts” as the ingredients.

Access CBD gummies in Australia

A mentioned earlier in the article, the current only legal pathway is to access CBD products via a medical practitioner. However, many online retailers are offering products under the title of &quotHemp oil&quot and &quotHemp gummies&quot – many of which they claim contain CBD content.

The Grey Market

One such company is Premium Jane, who have built up a reputation in the US as a trusted provider of quality CBD isolate products. Their fully established Australian arm currently offer a range of &quotfully legal&quot hemp oil and gummy products. Based on their product lab-sheets from DBLabs, it seems most of them do contain low doses of CBD.

The jury is still out to whether these grey market products are as advertised, as they are not yet approved by the ARTG. It&#39s also important to note that these range of products are purely sold as &quotHemp&quot products and they do not claim to cure any medical conditions.

See also  Can You Take CBD Gummies On An Empty Stomach

There are also many online distributors based in the US and Europe who offer international shipping of their CBD gummy products. Word of warning though – this is technically still illegal and we have heard from communities where their packages have been intercepted by Australian customs.

The Legal Path

If you are interested in finding a doctor in Australia with experience in prescribing cannabis products, check out our medicinal cannabis doctors directory to find one in your area.

We also have an in-depth guide on how to access CBD &amp medical marijuana in Australia if you wish to learn about the patient and doctor approval process.

CBD products and cannabis patients are steadily increasing year on year – with more than 100 different CBD products available in Australia since the start of 2020.

However, there are still limited CBD gummy products available for patients in the current market. The only accessible methods might be through importation with the help of a medical practitioner, or through one of the licensed cannabis suppliers in Australia.

We can only hope as cannabis laws mature in Australia and catch up with the rest of the world, more CBD products will become available for Australian patients.

analysis : It’s legal to buy over-the-counter cannabis in Australia — so why doesn’t my chemist sell it?

Since early 2021, the Therapeutic Goods Administration (TGA) has allowed the sale of low-dose cannabidiol (CBD) preparations over the counter at Australian pharmacies. But you won’t find any at your local chemist.

The situation is different overseas. In the United States, although not approved at a federal level, it is possible to buy over-the-counter products such as sweets containing CBD in several states. In the United Kingdom, low-dose CBD oil can be sold as a dietary supplement, but not a medicine.

CBD is a chemical found in the cannabis plant. Like tetrahydrocannabinol (THC), also found in cannabis, it does have psychoactive effects. It can make people sleepy and affect the brain’s electrical signals. Unlike THC, it won’t get you “high” or induce other psychotic effects.

Getting a medicine to market in Australia, even a non-prescription one, requires extensive research and investment. It might be too much for small cannabis producers to take on, and a turn-off for big pharmaceutical companies if that investment is at the expense of upcoming blockbuster drugs. And the process might not be worth it if research shows the benefit of cannabinoids is small compared with other therapies.

Getting a medicine to market in Australia, even a non-prescription one, requires extensive research and investment. ( Unsplash: Jan Zwarthoed )

Setting high standards

In Australia, it became legal to purchase products containing low-dose (less than 150 milligrams a day) CBD over the counter after the TGA down-scheduled the substance from a Schedule 4 (prescription medicine) to a Schedule 3 (pharmacist-only medicine).

But so far, no product containing CBD has been approved by the Australian Register of Therapeutic Goods (ARTG), which is a requirement of pharmacist sale. ARTG approval means regulatory quality data on its safety, contaminants, microbial content, shelf-life and efficacy meet the TGA standards and is known and tested in regulatory grade laboratories.

What’s the evidence for medical marijuana?

Advocates say medicinal cannabis offers effective relief when other treatments are failing. But Australian guidelines say there’s limited evidence to support its use.

The time and financial costs for drug development to meet the ARTG standards can be significant. Aspiring cannabis companies may not anticipate the difference between selling a product like cannabidiol compared to other products such as toys or clothing.

Expert clinical groups including physicians, psychiatrists, the Australian Medical Association and Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists opposed the down-scheduling, citing the lack safety data, lack of efficacy data, issues with product labelling and the potential for interactions with prescription medicines.

In fact there is only one regulatory-grade CBD product approved for use in Australia, Epidyolex, which is approved for treating forms of severe childhood epilepsy, and only available on prescription. (A drug called Sativex is also approved that contains both CBD and THC.)

See also  Can You Mix CBD Oil With Vape Liquid

From a patient-safety perspective, regulating formulation and ensuring safety and quality data has met the TGA bar is imperative. Proving effectiveness is reasonable too. By down-scheduling and yet insisting on ARTG approval, the use of illicit CBD products may decrease – a win for population health if it transpires.

For industry, the TGA’s decision to down-schedule but require ARTG approval could be seen as helpful to ensure quality and restrict supply. It has been estimated there is a potential for hundreds of millions of dollars of market in Australia and crop development is already underway. So, major investment into drug development by a CBD company could be financially rewarding, as long as the standards are met.

What could low-dose CBD be good for?

There are currently no recommended medical uses for low-dose CBD. Clinical trial data suggests a benefit of higher dose CBD for some children with a severe form of epilepsy who haven’t responded to other drugs. But it’s not clear whether the benefits could also have been explained by the fact patients also took Valium. And there were significant side effects reported that were higher in the CBD group.

Here’s a first look at how many Australians are taking medicinal cannabis

Christian Read insists while medical medicinal cannabis can’t cure him of the pain he experiences, it grants him some relief.

With some high-profile proponents including basketballer Lauren Jackson, there are increasing calls in many countries for patients, particularly those with chronic pain, to legally use cannabinoids. There are also claims low-dose CBD could help people with anxiety, insomnia, arthritis or inflammatory issues, but this has yet to be backed by research into effectiveness or safety.

We don’t know whether any cannabis business has applied to the TGA to have its product registered and been rejected due to failures on the safety, efficacy and quality side.

However, due to cannabis’ complicated extraction, synthesis, combinations, drug interactions and side-effects profile, it seems unlikely many non-medical companies would have the facilities, systems and people available in Australia to be able to achieve the required standards.

So far, big pharmaceutical companies have not shown significant interest in low-dose CBD. They may not be sure low-dose drugs will be recommended by doctors, or be waiting for more research. They may not judge CBD to be a potential blockbuster compared with other therapies in their pipelines.

There are some local producers exporting cannabis and embarking on clinical trials. Federal health minister Greg Hunt has said Australia is “poised to become a recognised leader in the global supply of the highest-quality medicinal cannabis products”.

Coming to a chemist soon?

If we are using cannabis as a medicine, we should make the same demands we do of other medicines to protect patient safety. This requires good manufacturing practice, good laboratory standards of measurement, appropriate labelling, and sufficient clinical information for informed patient consent.

Medical professionals should know what they are prescribing or recommending and be able to refer to dose-response data for each compound. They need to know the pharmacology and the drug interactions, the evidence for their use in specific conditions and any negative effects.

They also need to understand the legal, professional and regulatory obligations placed on prescribers and dispensers. If products are being bought at the chemist, they may interfere with other drugs or foods. Companies who want to sell such products in Australia will need to focus on bringing their drug development into line with regulatory standards. Time will tell how many can do that.

Jennifer Martin is Professor of Medicine and Chair of Clinical Pharmacology at the University of Newcastle and Catherine Lucas is a clinical pharmacologist, also at the University of Newcastle. This piece first appeared on The Conversation.

Posted 13 Dec 2021 13 Dec 2021 Mon 13 Dec 2021 at 7:30pm , updated 14 Dec 2021 14 Dec 2021 Tue 14 Dec 2021 at 5:23am

How useful was this post?

Click on a star to rate it!

Average rating 3 / 5. Vote count: 1

No votes so far! Be the first to rate this post.